Annals of Emergency Medicine
Volume 54, Issue 1 , Pages 83-85 , July 2009

Invasive Haemophilus influenzae Type b Disease in Five Young Children—Minnesota, 2008

  • Centers for Disease Control and Prevention

References 

  1. Centers for Disease Control and Prevention. Haemophilus b conjugate vaccines for prevention of Haemophilus influenzae type b disease among infants and children two months of age and older: recommendations of the ACIP. MMWR Morb Mortal Wkly Rep. 1991;40(RR-1):1–7
  2. Centers for Disease Control and Prevention. Interim recommendations for the use of Haemophilus influenzae type b (Hib) conjugate vaccines related to the recall of certain lots of Hib-containing vaccines (PedvaxHIB and Comvax). MMWR Morb Mortal Wkly Rep. 2007;56:1318–1320
  3. Centers for Disease Control and Prevention. Continued shortage of Haemophilus influenzae type b (Hib) conjugate vaccines and potential implications for Hib surveillance—United States, 2008. MMWR Morb Mortal Wkly Rep. 2008;57:1252–1255
  4. Schuchat A, Hilger T, Zell E, et al. Active bacterial core surveillance of the Emerging Infections Program network. Emerg Infect Dis. 2001;7:92–99
  5. Centers for Disease Control and Prevention. Progress toward elimination of Haemophilus influenzae type b disease among infants and children—United States, 1987-1993. MMWR Morb Mortal Wkly Rep. 1994;43:144–148
  6. Whitney CG, Farley MM, Hadler J, et al. Decline in invasive pneumococcal disease after the introduction of protein-polysaccharide conjugate vaccine. N Engl J Med. 2003;348:1737–1746
  7. Gray SJ, Trotter CL, Ramsay ME, et al. Epidemiology of meningococcal disease in England and Wales 1993/94 to 2003/04: contribution and experiences of the Meningococcal Reference Unit. J Med Microbiol. 2006;55:887–896
  8. Oh SY, Griffiths D, John T, et al. School-aged children: a reservoir for continued circulation of Haemophilus influenzae type b in the United Kingdom. J Infect Dis. 2008;197:1275–1281
  9. Freed GL, Davis MM, Clark SJ. Variation in public and private supply of pneumococcal conjugate vaccine during a shortage. JAMA. 2003;289:575–578
  10. Stokley S, Santoli JM, Willis B, et al. Impact of vaccine shortages on immunization programs and providers. Am J Prev Med. 2004;26:15–21

 Editor's note: This article is part of a regular series on emerging infection from the Centers for Disease Control and Prevention (CDC) and the EMERGEncy ID NET, an emergency department–based and CDC-collaborative surveillance network. Important infectious disease public health information with relevance to emergency physicians is reported. The goal of this series is to advance knowledge about communicable diseases in emergency medicine and foster cooperation between the front line of clinical medicine and public health agencies.

PII: S0196-0644(09)00529-0

doi: 10.1016/j.annemergmed.2009.05.019

Annals of Emergency Medicine
Volume 54, Issue 1 , Pages 83-85 , July 2009

Article Tools